Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurobiology of Disease

• Publication date

  2007-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.NBD.2006.11.013PMID 17254792PMCID PMC1899875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally.

  2006cited by this paper
• Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis

  2006cited by this paper
• Prevalence of Parkinson's disease in the L'Aquila district, central Italy

  2005cited by this paper
• Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.

  2005cited by this paper
• Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice.

  2004cited by this paper
• Risk factors for dopaminergic neuron loss in human α‐synuclein transgenic mice

  2004cited by this paper
• Aging of the nigrostriatal system in the squirrel monkey

  2004cited by this paper
• Description of Parkinson's Disease as a Clinical Syndrome

  2003cited by this paper
• Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.

  2003cited by this paper
• Age‐related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype

  2003cited by this paper
• Changes in somatodendritic but not terminal dopamine
regulation in aged rhesus monkeys

  2002cited by this paper
• Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys.

  2001cited by this paper
• Preservation of midbrain catecholaminergic neurons in very old human subjects.

  2000cited by this paper
• The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

  1999cited by this paper
• Age-associated changes in rhesus CNS composition identified by MRI.

  1999cited by this paper
• Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys

  1998cited by this paper
• EPIDEMIOLOGY OF PARKINSON'S DISEASE

  1996cited by this paper
• The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993.

  1995cited by this paper
• A stereological study of substantia nigra in young and old rhesus monkeys.

  1995cited by this paper
• Methods in cell transplantation

  1995cited by this paper
• Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys.

  1995cited by this paper
• Aging and the nigrostriatal dopamine system: a non-human primate study.

  1994cited by this paper
• Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indices

  1993cited by this paper
• Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease

  1992cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP

  1990cited by this paper
• Compensations after lesions of central dopaminergic neurons: some clinical and basic implications.

  1990cited by this paper
• Intracarotid 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Administration: Biochemical and Behavioral Observations in a Primate Model of Hemiparkinsonism

  1990cited by this paper
• Clinical relevance of specific IgG antibodies to cardiolipin

  1989cited by this paper
• Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization

  1989cited by this paper
• Dopaminergic Changes in the Basal Ganglia A Generalized Phenomenon of Aging in Mammals a

  1988cited by this paper
• Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

  1986cited by this paper
• Aetiology of Parkinson's disease.

  1983cited by this paper
• Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys.

  1981cited by this paper

• An update on mammalian and non-mammalian animal models for biomarker development in neurodegenerative disorders

  2025cites this paper
• The role of the brain renin-angiotensin system in Parkinson´s disease

  2024cites this paper
• Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function—Not a New Concept, but Neglected Reality

  2024cites this paper
• Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson’s Disease

  2024cites this paper
• Prevalence of Parkinson’s disease among adults aged 45 years and older in China: a cross-sectional study based on the China health and retirement longitudinal study

  2024cites this paper
• Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life span

  2024cites this paper
• Role of Animal Models in Parkinson's Disease (PD): What role they play in preclinical translational research.

  2023cites this paper
• Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates

  2023cites this paper
• Nigral-specific increase in ser31 phosphorylation compensates for tyrosine hydroxylase protein and nigrostriatal neuron loss: Implications for delaying parkinsonian signs.

  2023cites this paper
• Aging, Parkinson’s Disease, and Models: What Are the Challenges?

  2023cites this paper
• Nigral-specific increase in ser31 tyrosine hydroxylase phosphorylation offsets dopamine loss and forestalls hypokinesia onset during progressive nigrostriatal neuron loss

  2022cites this paper
• Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures

  2022cites this paper
• Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)

  2022cites this paper
• “Reframing” dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications

  2022cites this paper
• Longitudinal Association between Sarcopenia and Cognitive Impairment among Older Adults in Rural Malaysia

  2022cites this paper
• Cortical D1 and D2 dopamine receptor availability modulate methylphenidate-induced changes in brain activity and functional connectivity

  2022cites this paper
• Modulation of nigral dopamine signaling mitigates parkinsonian signs of aging: evidence from intervention with calorie restriction or inhibition of dopamine uptake

  2022cites this paper
• Impact of aging on animal models of Parkinson's disease

  2022cites this paper
• LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration

  2022cites this paper
• Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease

  2022cites this paper
• Cohort profile: The Australian Parkinson's Genetics Study (APGS)

  2021cites this paper
• Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model.

  2021cites this paper
• Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy.

  2021cites this paper
• Sapajus apella as a model for the development of novel therapeutic approaches for Parkinson's disease

  2021cites this paper
• Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s Disease

  2021cites this paper
• Strain- and age-dependent features of the nigro-striatal circuit in three common laboratory mouse strains, C57BL/6J, A/J, and DBA/2J - Implications for Parkinson’s disease modeling

  2020cites this paper
• Inflammation in Experimental Models of α‐Synucleinopathies

  2020influential citation
• Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty

  2020cites this paper
• Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review

  2020cites this paper
• Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease

  2020cites this paper
• Glia-Derived Extracellular Vesicles in Parkinson’s Disease

  2020cites this paper
• Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia

  2020cites this paper
• Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease

  2020cites this paper
• Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis

  2020cites this paper
• Parkinson's disease, aging and adult neurogenesis: Wnt/β‐catenin signalling as the key to unlock the mystery of endogenous brain repair

  2020cites this paper
• Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging.

  2020cites this paper
• Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.

  2019cites this paper
• Ceruloplasmin in Parkinson's disease and the nonmotor symptoms

  2018cites this paper
• 10 Targeting Tyrosine Hydroxylase to Improve Bradykinesia

  2018cites this paper
• Neural Stem Cell Grafts Promote Astroglia‐Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β‐Catenin Signaling

  2018cites this paper
• Curiosity in old age: A possible key to achieving adaptive aging

  2018cites this paper
• Aging-related dysregulation in enteric dopamine and angiotensin system interactions: implications for gastrointestinal dysfunction in the elderly

  2018cites this paper
• Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain

  2018influential citation
• The use of nonhuman primate models to understand processes in Parkinson’s disease

  2018cites this paper
• Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease

  2018cites this paper
• Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency

  2018cites this paper
• Enriched environment elevates expression of growth associated protein-43 in the substantia nigra of SAMP8 mice

  2018cites this paper
• Conditioning Against the Pathology of Parkinson's disease.

  2018cites this paper
• Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson’s Disease

  2018cites this paper
• Engrailed homeoprotein blocks degeneration in adult dopaminergic neurons through LINE-1 repression

  2017cites this paper
• Aging and Parkinson’s Disease: Different Sides of the Same Coin?

  2017cites this paper
• Parkinson Disease: An Evolutionary Perspective

  2017cites this paper
• Dissociation of Striatal Dopamine and Tyrosine Hydroxylase Expression from Aging-Related Motor Decline: Evidence from Calorie Restriction Intervention

  2017cites this paper
• Therapeutic potential of agmatine for CNS disorders

  2017cites this paper
• Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration

  2017cites this paper
• The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.

  2017cites this paper
• Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic

  2016cites this paper
• Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.

  2016cites this paper
• Aging-related Increase in Rho Kinase Activity in the Nigral Region Is Counteracted by Physical Exercise.

  2016cites this paper
• Nigral dopaminergic PAK4 prevents neurodegeneration in rat models of Parkinson’s disease

  2016cites this paper
• Interactive effects of age and multi-gene profile on motor learning and sensorimotor adaptation.

  2016cites this paper
• Different relationships between central dopamine system and sub-processes of inhibition: Spontaneous eye blink rate relates with N2 but not P3 in a Go/Nogo task.

  2016cites this paper
• Initiation of calorie restriction in middle-aged male rats attenuates aging-related motoric decline and bradykinesia without increased striatal dopamine.

  2016influential citation
• COMPARATIVE ANALYSIS OF POTENTIALITY OF ESCULIN AND HINOKITOL (Β-THUJAPLICIN) AS ANTI-PARKINSONISM DRUGS: A PILOT IN SILICO STUDY

  2016cites this paper
• Cell Therapy in Parkinson's Disease: Understanding the Challenge

  2016cites this paper
• The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.

  2015cites this paper
• Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

  2015cites this paper
• Related factors and prevalence of Parkinson's disease among Uygur residents in Hetian, Xinjiang Uygur Autonomous Region.

  2015cites this paper
• Primate Models of Complications Related to Parkinson Disease Treatment

  2015cites this paper
• Wnt/β‐Catenin Signaling Is Required to Rescue Midbrain Dopaminergic Progenitors and Promote Neurorepair in Ageing Mouse Model of Parkinson's Disease

  2014cites this paper
• No Direct Projection is Observed from the Substantia Nigra to the Dorsal Vagus Complex in the Rat

  2014cites this paper
• Targeting Wnt signaling at the neuroimmune interfacefordopaminergicneuroprotection/repairin

  2014cites this paper
• Brain renin-angiotensin system and dopaminergic cell vulnerability

  2014cites this paper
• Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.

  2014cites this paper
• Calcium signaling in Parkinson’s disease

  2014cites this paper
• ser31 tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6‐OHDA lesion

  2014cites this paper
• Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update

  2014cites this paper
• Aging-related dysregulation of dopamine and angiotensin receptor interaction.

  2014cites this paper
• Getting to compliance in forced exercise in rodents: a critical standard to evaluate exercise impact in aging-related disorders and disease.

  2014cites this paper
• Sex differences in dopaminergic neurons of substantia nigra pars compacta of adult and aged rats: a histological and immunohistochemical study

  2013cites this paper
• A Role for the Brain RAS in Alzheimer’s and Parkinson’s Diseases

  2013cites this paper
• Dopamine‐Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease

  2013cites this paper
• Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells.

  2013cites this paper
• Aging-Induced Nrf2-ARE Pathway Disruption in the Subventricular Zone Drives Neurogenic Impairment in Parkinsonian Mice via PI3K-Wnt/β-Catenin Dysregulation

  2013cites this paper
• Dopamine-Dependent Compensation Maintains Motor Behavior in Mice with Developmental Ablation of Dopaminergic Neurons

  2013cites this paper
• BDNF Val66Met polymorphism and goal-directed behavior in healthy elderly - evidence from auditory distraction

  2013cites this paper
• Impact of five SNPs in dopamine‐related genes on executive function

  2013cites this paper
• Characterizing Aging in the Human Brainstem Using Quantitative Multimodal MRI Analysis

  2013cites this paper
• Differential aging-related changes of D1, D2, and D3 dopamine receptor expression in the striatum

  2013cites this paper
• Cost of Time in Motor Control

  2012cites this paper
• Brain gene therapy: triumph and future of nanotechnology

  2012cites this paper
• Review Article Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease

  2012cites this paper
• The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias.

  2012cites this paper
• Protein-Thiol Oxidation and Cell Death: Regulatory Role of Glutaredoxins

  2012cites this paper
• Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum.

  2012cites this paper
• The aging striatal dopamine function.

  2012cites this paper
• Neurotoxin-based models of Parkinson's disease.

  2012cites this paper
• Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

  2012influential citation
• Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease.

  2012cites this paper
• Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.

  2012influential citation